TRIKAFTA 100mg/50mg/75mg + 75mg gran sach 56 pce

7680692120021 CH-69212 R07AX32 03.99.0.
TRIKAFTA 100mg/50mg/75mg + 75mg gran sach 56 pce
TRIKAFTA 100mg/50mg/75mg + 75mg gran sach 56 pce
TRIKAFTA 100mg/50mg/75mg + 75mg gran sach 56 pce
1 / 3
google

Details

GTIN
7680692120021
Pharmacode
-
Product number
6921201
CPT
-
Packaging group
56
Unit
Sachet(s)
Composition
Granulat Morgendosis (elexacaftorum 100 mg / tezacaftorum 50 mg / ivacaftorum 75 mg): elexacaftorum 100 mg, tezacaftorum 50 mg, ivacaftorum 75 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 235.7 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 3.44 mg. Granulat Abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 109.8 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 1.49 mg.

Articles (1)

Trikafta 100 mg / 50 mg / 75 mg, 75 mg, Granulat
Granulat
56
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
elexacaftorum
100.0 MG Substance Wirkstoff (Principe actif)
ivacaftorum
75.0 MG Substance Wirkstoff (Principe actif)
hypromellosi acetas succinas
- Substance HNIDK
tezacaftorum
50.0 MG Substance Wirkstoff (Principe actif)
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ivacaftorum
75.0 MG Substance Wirkstoff (Principe actif)
hypromellosum
- Substance HNIDK
lactosum monohydricum
109.8 MG Substance HBESI
hypromellosi acetas succinas
- Substance HNIDK
mannitolum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
sucralosum
- Substance HNIDK
lactosum monohydricum
235.7 MG Substance HBESI
mannitolum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
sucralosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
natrium
- Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 14565.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Vertex Pharmaceuticals (CH) GmbH

6300 Zug

Authorization information

Swissmedic authorization number
69212
Drug name
Trikafta, Granulat
Galenic form
GRB
ATC Code
R07AX32
Authorization status
Z
Dispensation category
A
First authorization
13/06/2024
Authorization expiration date
12/06/2029
IT number
03.99.0.
Domain
Human medicine
Field of application
zystische Fibrose bei Kindern von 2 bis <6 Jahren

Packaging details

Description (FR)
TRIKAFTA 100mg/50mg/75mg + 75mg gran sach 56 pce
Description (DE)
TRIKAFTA 100mg/50mg/75mg + 75mg Gran Btl 56 Stk
Market launch
13/06/2024
Narcotic (BTM)
No

Other packaging sizes

TRIKAFTA 80mg/40mg/60mg + 59.5mg gran sach 56 pce
56 SAC
View
Buy us a coffee Explore the data